OBR Daily Commentary


The FDA Seeks a New Way to Review Old Drugs Without Causing Prices to Soar

(Kaiser Health News) Apr 15, 2021 - Chuck Peterson of Omaha, Nebraska, recently experienced a swollen, painful knuckle caused by arthritis. He got a prescription for colchicine.

Read Article arrow

Jeff Patton, MD (Posted: April 15, 2021)


Manufacturers "gaming" the system in this way is nothing short of shameful. Yet another reason that healthcare needs to move toward free market principles where transparency and competition eliminate these "opportunities" to extract value from a system as opposed to adding value. Shameful.



Add Comment 1 Comment(s)